Ranitidine
- Product NDC
- 43063-844
- 11-digit product format
- 430630844
- Labeler code
- 43063
- Product ID
- 43063-844_8642b8e4-d19d-f12a-e053-2a91aa0a14bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-844-01 | EA - Each | 43063-844 | 02ed905c-d7e8-4b65-baa7-afb22c2184d9 | 1 | 2018-09-05 |
| 43063-844-14 | EA - Each | 43063-844 | 1b7f717c-fdd6-46ac-8d49-114ea1932f88 | 1 | 2018-07-03 |
| 43063-844-15 | EA - Each | 43063-844 | 53ff6e75-0b5a-4692-9aed-17aa92279478 | 1 | 2018-09-05 |
| 43063-844-20 | EA - Each | 43063-844 | 91fe2720-4510-44d7-b8b2-f74ea8ca1046 | 1 | 2018-08-13 |
| 43063-844-30 | EA - Each | 43063-844 | d17551c8-91de-4072-9e19-cad02ffdb502 | 1 | 2018-05-09 |
| 43063-844-60 | EA - Each | 43063-844 | ea1f3333-32b7-4b87-a647-3aa9df55ae00 | 1 | 2018-05-09 |
| 43063-844-90 | EA - Each | 43063-844 | 8ec2a08d-84cf-4e90-9d13-5f2391caaf05 | 1 | 2018-08-13 |